↓ Skip to main content

A predictive tool particularly designed for elderly myeloma patients presenting with spinal cord compression

Overview of attention for article published in BMC Cancer, April 2016
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
20 Mendeley
Title
A predictive tool particularly designed for elderly myeloma patients presenting with spinal cord compression
Published in
BMC Cancer, April 2016
DOI 10.1186/s12885-016-2325-y
Pubmed ID
Authors

Dirk Rades, Antonio Jose Conde-Moreno, Jon Cacicedo, Theo Veninga, Niklas Gebauer, Tobias Bartscht, Steven E. Schild

Abstract

This study was performed to design a predictive tool that allows the estimation of overall survival (OS) of elderly myeloma patients (aged ≥65 years) presenting with myeloma-induced spinal cord compression (SCC). One-hundred-and-sixteen patients irradiated for motor deficits of the legs due to myeloma-induced spinal cord compression were retrospectively evaluated. Ten characteristics were analyzed for OS including age, interval between myeloma diagnosis and radiotherapy, other osseous myeloma lesions, myeloma type, gender, time developing motor deficits, number of affected vertebrae, ECOG-PS, pre-radiotherapy ambulatory status, and fractionation regimen. Characteristics that achieved significance on multivariate analysis were included in the predictive tool. The score for each characteristic was obtained from the 1-year OS rate divided by 10. The sum of these scores represented the prognostic score for each patient. On multivariate analysis, myeloma type (hazard ratio 3.31; 95 %-confidence interval 1.75-6.49; p < 0.001), ECOG-PS (HR 5.33; 95 %-CI 2.67-11.11; p < 0.001), ambulatory status (HR 2.71; 95 % CI 1.65-4.57; p < 0.001), and age (HR 1.95; 95 % CI 1.03-3.78; p = 0.040) were significantly associated with survival. Sum scores ranged from 18 to 32 points. Based on the sum scores, three prognostic groups were designed: 18-19, 21-28 and 29-32 points. The corresponding 1-year survival rates were 0, 43 and 96 %, respectively (p < 0.001). This new predictive tool has been specifically designed for elderly myeloma patients with SCC. It allows estimating the survival prognosis of this patient group and supports the treating physicians when looking for the optimal treatment approach for an individual patient.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 15%
Student > Doctoral Student 3 15%
Student > Ph. D. Student 2 10%
Lecturer 2 10%
Researcher 2 10%
Other 3 15%
Unknown 5 25%
Readers by discipline Count As %
Medicine and Dentistry 8 40%
Nursing and Health Professions 2 10%
Biochemistry, Genetics and Molecular Biology 1 5%
Psychology 1 5%
Computer Science 1 5%
Other 2 10%
Unknown 5 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2016.
All research outputs
#19,054,237
of 23,613,071 outputs
Outputs from BMC Cancer
#5,567
of 8,487 outputs
Outputs of similar age
#220,544
of 299,961 outputs
Outputs of similar age from BMC Cancer
#76
of 121 outputs
Altmetric has tracked 23,613,071 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,487 research outputs from this source. They receive a mean Attention Score of 4.4. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 299,961 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.